2003 Volume 21 Pages 151-155
Radio frequency ablation (RFA) has been recently applied as an option of minimally invasive treatment of renal cell carcinoma (RCC). However, indication of this modality remains critical issue because of its lack of complete tumor destruction and its uncertainty of long terms efficacy for patient who might be a candidate for standard surgical treatment. We report the efficacy and limitation of RFA for heavily selected 6 cases of clinically localized RCC which were contraindicated for surgical treatment under general anesthesia.